Linical
Linical Accelovance is a market-leading, midsized, global CRO with a significant footprint across North America, Europe and Asia-Pacific. With operations in more than 20 countries, Linical Accelovance is a full-service drug development partner, uniquely capable of conducting large-scale, multinational studies, while delivering personalized, hands-on service. Our areas of expertise include Phase I-IV oncology, hematology, vaccine, CNS and general medicine trials. We leverage operational knowledge and patient recruitment/retention strategies to support clients in successful clinical trials.